New methodological strategies in haematology using cell-derived microvesicles - Archive ouverte HAL Access content directly
Conference Papers Year : 2013

New methodological strategies in haematology using cell-derived microvesicles

(1)
1

Abstract

Cellular microvesicles are membrane nanometric vesicles, 0.1-1 µm in size, released into body fluids by activated cells or during apoptosis in a variety of pathological conditions. Microvesicles expose phosphatidylserine and tissue factor and have been proposed as pathogenic markers, key players of the haemostatic response. In recent years, tumour microvesicles have evolved as potential biomarkers. Indeed, tumour cells are able to constitutively release large amounts of microvesicles bearing tumour specific antigens. In hematologic malignancies the study of microvesicles is gaining increased interest and the generation of leukaemia/lymphoma cell-derived microvesicles may constitute a new tool for diagnosis and clinical/therapeutic follow-up.
Fichier principal
Vignette du fichier
RdH2013_14_Supl_1_S38NewHematolMVs.pdf (619.84 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00851471 , version 1 (14-08-2013)

Identifiers

  • HAL Id : inserm-00851471 , version 1

Cite

Eduardo Angles-Cano. New methodological strategies in haematology using cell-derived microvesicles: New methodological strategies in haematology. Nuevas Metodologias en el Estudio de Enfermedades Hematologicas, Apr 2013, Mazatlan, Mexico. pp.S38-S41. ⟨inserm-00851471⟩
273 View
63 Download

Share

Gmail Facebook Twitter LinkedIn More